| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.09. | FULLSHARE (00607): LETTER TO NON-REGISTERED HOLDERS - NOTIFICATION OF PUBLICATION OF INTERIM REPORT 2026 AND REQUEST FORM | - | HKEx | ||
| 24.09. | FULLSHARE (00607): LETTER TO REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF INTERIM REPORT 2026 AND CHANGE REQUEST FORM | - | HKEx | ||
| 24.09. | FULLSHARE (00607): INTERIM REPORT 2026 | - | HKEx | ||
| 31.08. | FULLSHARE (00607): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026 | - | HKEx | ||
| 25.08. | FULLSHARE (00607): CHANGE OF NAME OF AUDITOR | 1 | HKEx | ||
| 24.08. | FULLSHARE (00607): PROFIT WARNING | 1 | HKEx | ||
| FULLSHARE Aktie jetzt für 0€ handeln | |||||
| 19.08. | FULLSHARE (00607): DATE OF BOARD MEETING | 2 | HKEx | ||
| 05.08. | FULLSHARE (00607): VOLUNTARY ANNOUNCEMENT IN RELATION TO FURTHER INVESTIGATION AND INTERNAL CONTROL REVIEW TO BE CONDUCTED BY CHINA HIGH SPEED TRANSMISSION ... | - | HKEx | ||
| 31.07. | FULLSHARE (00607): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 31.07. | FULLSHARE (00607): COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER THE GENERAL MANDATE | 2 | HKEx | ||
| 24.07. | FULLSHARE (00607): POLL RESULTS OF THE ADJOURNED ANNUAL GENERAL MEETING HELD ON 24 JULY 2026 | - | HKEx | ||
| 17.07. | FULLSHARE (00607): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE | 3 | HKEx | ||
| 03.07. | FULLSHARE (00607): VOLUNTARY ANNOUNCEMENT | 2 | HKEx | ||
| 02.07. | FULLSHARE (00607): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE | 3 | HKEx | ||
| 29.06. | FULLSHARE (00607): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 JUNE 2026 | 2 | HKEx | ||
| 26.06. | FULLSHARE (00607): LETTER TO NON-REGISTERED HOLDERS - NOTIFICATION OF PUBLICATION OF ANNUAL REPORT 2025 AND CIRCULAR CONTAINING NOTICE OF ADJOURNED ANNUAL ... | - | HKEx | ||
| 26.06. | FULLSHARE (00607): LETTER TO REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF ANNUAL REPORT 2025 AND CIRCULAR CONTAINING NOTICE OF ADJOURNED ANNUAL ... | 1 | HKEx | ||
| 26.06. | FULLSHARE (00607): NOTICE OF ADJOURNED ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 26.06. | FULLSHARE (00607): FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE 2025 ADJOURNED ANNUAL GENERAL MEETING TO BE CONVENED ON FRIDAY, 24 JULY 2026 AT 10:00 ... | - | HKEx | ||
| 26.06. | FULLSHARE (00607): (1) PROPOSED ADOPTION OF AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND REPORTS OF THE DIRECTORS AND AUDITOR; (2) PROPOSED RE-APPOINTMENT ... | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PING AN HEALTHCARE | 0,602 | 0,00 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, 3 DECEMBER 2026 | ||
| WEIGAO GROUP | 0,360 | -3,25 % | WEIGAO GROUP (01066): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK | ||
| CHINA MEDICAL SYSTEM | 1,170 | +0,86 % | China Medical System Holdings Limited: CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo Treatment | SHENZHEN, Nov 4, 2026 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that its subsidiary, Rxilient Medical received approval from the Health Sciences... ► Artikel lesen | |
| GRAND PHARMACEUTICAL GROUP | 0,476 | +0,85 % | GRAND PHARMA: Chinese Medicine Innovative Drug for Preventive Migraine Treatment Completes First Patient Enrollment in Phase II Clinical Trial | ||
| TONG REN TANG TECHNOLOGIES | 0,318 | -1,85 % | TONG REN TANG (01666): VOLUNTARY ANNOUNCEMENT IN RELATION TO NON-PARTICIPATION IN THE ACQUISITION OF 60% OF THE SHARES OF TIANJIN TRT AND THE RELATED ... | ||
| FRESENIUS | 53,62 | +0,62 % | EQS-DD: Fresenius SE & Co. KGaA: Dr. Christian Pawlu, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
09.11.2026 / 09:49... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,110 | +1,39 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 38 auf 37,50 Euro gesenkt und die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,950 | +0,34 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Siemens Healthineers von 50 auf 55 Euro angehoben und die Einstufung auf "Buy" belassen. Das vierte Geschäftsquartal habe... ► Artikel lesen | |
| HEARTFLOW | 48,330 | -0,27 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| PROGYNY | 36,180 | 0,00 % | Rekorde bei Familienplanung: Progyny glänzt mit blitzsauberer Bilanz und massiven Rückkäufen | Hier an der Wall Street in New York wird oft das schnelle Geld gesucht. Doch die wahren Börsenperlen findet man häufig in lukrativen Nischen, in denen ein Unternehmen zum unverzichtbaren Marktführer... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,500 | 0,00 % | NSE - Starling Oncology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| BRIGHTSPRING HEALTH SERVICES | 71,21 | 0,00 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| GENEDX | 52,36 | -0,02 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| OTTOBOCK | 40,050 | +2,17 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): 9-Monatszahlen
Ottobock setzt Wachstumskurs bei veränderten Marktbedingungen fort
12.11.2026 / 07:30 CET/CEST
Für den... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 11,500 | 0,00 % | RBC Capital reiterates Aveanna Healthcare stock rating at Outperform |